HomeLPGO • STO
add
Lipigon Pharmaceuticals AB
Previous close
kr 0.19
Day range
kr 0.18 - kr 0.21
Year range
kr 0.16 - kr 0.69
Market cap
27.07M SEK
Avg Volume
391.78K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 8.97M | -44.11% |
Operating expense | 1.89M | -12.76% |
Net income | -415.00K | -105.82% |
Net profit margin | -4.63 | -110.42% |
Earnings per share | — | — |
EBITDA | -496.00K | -106.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 19.48M | 12.53% |
Total assets | 30.31M | -13.69% |
Total liabilities | 5.07M | -32.72% |
Total equity | 25.24M | — |
Shares outstanding | 148.33M | — |
Price to book | 1.10 | — |
Return on assets | -4.48% | — |
Return on capital | -5.38% | — |
Cash Flow
Net change in cash
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -415.00K | -105.82% |
Cash from operations | -8.51M | 18.09% |
Cash from investing | -235.00K | — |
Cash from financing | 4.24M | -81.88% |
Net change in cash | -4.53M | -134.72% |
Free cash flow | -8.70M | 33.51% |
About
Founded
2010
Website
Employees
6